There is evidence on the role of increased plasma levels of fibrinogen and endogenous TLR4 ligands in breast cancer cell proliferation, survival, metastasis of cancer cells, and prognosis in patients (60, 61), however, their roles in prostate cancer are unclear. Here, TLR4 is linked to prostate cancer.